175 related articles for article (PubMed ID: 18985800)
1. Ste20-related proline/alanine-rich kinase: a novel regulator of intestinal inflammation.
Yan Y; Merlin D
World J Gastroenterol; 2008 Oct; 14(40):6115-21. PubMed ID: 18985800
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Ste20-related proline/alanine-rich kinase exacerbates experimental colitis in mice.
Yan Y; Laroui H; Ingersoll SA; Ayyadurai S; Charania M; Yang S; Dalmasso G; Obertone TS; Nguyen H; Sitaraman SV; Merlin D
J Immunol; 2011 Aug; 187(3):1496-505. PubMed ID: 21705622
[TBL] [Abstract][Full Text] [Related]
3. Cloning and characterization of a new intestinal inflammation-associated colonic epithelial Ste20-related protein kinase isoform.
Yan Y; Nguyen H; Dalmasso G; Sitaraman SV; Merlin D
Biochim Biophys Acta; 2007 Feb; 1769(2):106-16. PubMed ID: 17321610
[TBL] [Abstract][Full Text] [Related]
4. Knockout of Ste20-like proline/alanine-rich kinase (SPAK) attenuates intestinal inflammation in mice.
Zhang Y; Viennois E; Xiao B; Baker MT; Yang S; Okoro I; Yan Y
Am J Pathol; 2013 May; 182(5):1617-28. PubMed ID: 23499375
[TBL] [Abstract][Full Text] [Related]
5. Ste20-related proline/alanine-rich kinase (SPAK) regulated transcriptionally by hyperosmolarity is involved in intestinal barrier function.
Yan Y; Dalmasso G; Nguyen HT; Obertone TS; Sitaraman SV; Merlin D
PLoS One; 2009; 4(4):e5049. PubMed ID: 19343169
[TBL] [Abstract][Full Text] [Related]
6. Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis.
Terc J; Hansen A; Alston L; Hirota SA
Eur J Pharm Sci; 2014 May; 55():12-9. PubMed ID: 24486481
[TBL] [Abstract][Full Text] [Related]
7. SPAK and OSR1: STE20 kinases involved in the regulation of ion homoeostasis and volume control in mammalian cells.
Delpire E; Gagnon KB
Biochem J; 2008 Jan; 409(2):321-31. PubMed ID: 18092945
[TBL] [Abstract][Full Text] [Related]
8. K-Cl cotransporters, cell volume homeostasis, and neurological disease.
Kahle KT; Khanna AR; Alper SL; Adragna NC; Lauf PK; Sun D; Delpire E
Trends Mol Med; 2015 Aug; 21(8):513-23. PubMed ID: 26142773
[TBL] [Abstract][Full Text] [Related]
9. WNK pathways in cancer signaling networks.
Gallolu Kankanamalage S; Karra AS; Cobb MH
Cell Commun Signal; 2018 Nov; 16(1):72. PubMed ID: 30390653
[TBL] [Abstract][Full Text] [Related]
10. Future therapeutic potential of SAP-1 in inflammatory bowel diseases.
Kotani T; Murata Y; Saito Y; Matozaki T
Expert Rev Gastroenterol Hepatol; 2016 Dec; 10(12):1313-1315. PubMed ID: 27705005
[No Abstract] [Full Text] [Related]
11. Inhibition of WNK3 Kinase Signaling Reduces Brain Damage and Accelerates Neurological Recovery After Stroke.
Begum G; Yuan H; Kahle KT; Li L; Wang S; Shi Y; Shmukler BE; Yang SS; Lin SH; Alper SL; Sun D
Stroke; 2015 Jul; 46(7):1956-1965. PubMed ID: 26069258
[TBL] [Abstract][Full Text] [Related]
12. SPAK, a STE20/SPS1-related kinase that activates the p38 pathway.
Johnston AM; Naselli G; Gonez LJ; Martin RM; Harrison LC; DeAizpurua HJ
Oncogene; 2000 Aug; 19(37):4290-7. PubMed ID: 10980603
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological targeting of SPAK kinase in disorders of impaired epithelial transport.
Zhang J; Karimy JK; Delpire E; Kahle KT
Expert Opin Ther Targets; 2017 Aug; 21(8):795-804. PubMed ID: 28679296
[TBL] [Abstract][Full Text] [Related]
14. Kinase suppressor of Ras determines survival of intestinal epithelial cells exposed to tumor necrosis factor.
Yan F; John SK; Polk DB
Cancer Res; 2001 Dec; 61(24):8668-75. PubMed ID: 11751383
[TBL] [Abstract][Full Text] [Related]
15. Dietary salt intake regulates WNK3-SPAK-NKCC1 phosphorylation cascade in mouse aorta through angiotensin II.
Zeniya M; Sohara E; Kita S; Iwamoto T; Susa K; Mori T; Oi K; Chiga M; Takahashi D; Yang SS; Lin SH; Rai T; Sasaki S; Uchida S
Hypertension; 2013 Nov; 62(5):872-8. PubMed ID: 24019400
[TBL] [Abstract][Full Text] [Related]
16. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
17. The Role of HSP70 Heat Shock Proteins in the Pathogenesis and Treatment of Inflammatory Bowel Diseases.
Samborski P; Grzymisławski M
Adv Clin Exp Med; 2015; 24(3):525-30. PubMed ID: 26467144
[TBL] [Abstract][Full Text] [Related]
18. Targeting Mitogen-Activated Protein Kinases by Natural Products: A Novel Therapeutic Approach for Inflammatory Bowel Diseases.
Zobeiri M; Momtaz S; Parvizi F; Tewari D; Farzaei MH; Nabavi SM
Curr Pharm Biotechnol; 2020; 21(13):1342-1353. PubMed ID: 31840607
[TBL] [Abstract][Full Text] [Related]
19. SPAK mediates KCC3-enhanced cervical cancer tumorigenesis.
Chiu MH; Liu HS; Wu YH; Shen MR; Chou CY
FEBS J; 2014 May; 281(10):2353-65. PubMed ID: 24655550
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Novel SPAK Inhibitors That Block WNK Kinase Signaling to Cation Chloride Transporters.
Kikuchi E; Mori T; Zeniya M; Isobe K; Ishigami-Yuasa M; Fujii S; Kagechika H; Ishihara T; Mizushima T; Sasaki S; Sohara E; Rai T; Uchida S
J Am Soc Nephrol; 2015 Jul; 26(7):1525-36. PubMed ID: 25377078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
